DK0828703T3 - Asymmetrisk syntese af (-)-6-chlor-4-cyclopropylethynyl-4-trifluormethyl-1,4-dihydro-2H-3,1-benzoxazin-2-on - Google Patents
Asymmetrisk syntese af (-)-6-chlor-4-cyclopropylethynyl-4-trifluormethyl-1,4-dihydro-2H-3,1-benzoxazin-2-onInfo
- Publication number
- DK0828703T3 DK0828703T3 DK96920322T DK96920322T DK0828703T3 DK 0828703 T3 DK0828703 T3 DK 0828703T3 DK 96920322 T DK96920322 T DK 96920322T DK 96920322 T DK96920322 T DK 96920322T DK 0828703 T3 DK0828703 T3 DK 0828703T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclopropylethynyl
- benzoxazin
- dihydro
- trifluoromethyl
- chloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/68—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/70—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/450,330 US5633405A (en) | 1995-05-25 | 1995-05-25 | Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one |
| PCT/US1996/007294 WO1996037457A1 (en) | 1995-05-25 | 1996-05-21 | Asymmetric synthesis of (-) 6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2h-3,1-benzoxazin-2-one |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0828703T3 true DK0828703T3 (da) | 2000-11-20 |
Family
ID=23787667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96920322T DK0828703T3 (da) | 1995-05-25 | 1996-05-21 | Asymmetrisk syntese af (-)-6-chlor-4-cyclopropylethynyl-4-trifluormethyl-1,4-dihydro-2H-3,1-benzoxazin-2-on |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US5633405A (da) |
| EP (1) | EP0828703B1 (da) |
| JP (1) | JP2839717B2 (da) |
| KR (1) | KR100399511B1 (da) |
| CN (1) | CN1119319C (da) |
| AR (1) | AR002997A1 (da) |
| AT (1) | ATE196463T1 (da) |
| AU (1) | AU709273B2 (da) |
| BR (1) | BR9608839A (da) |
| CA (1) | CA2220389C (da) |
| CZ (1) | CZ292848B6 (da) |
| DE (1) | DE69610422T2 (da) |
| DK (1) | DK0828703T3 (da) |
| EA (1) | EA000107B1 (da) |
| ES (1) | ES2151666T3 (da) |
| GR (1) | GR3034897T3 (da) |
| HR (1) | HRP960233B1 (da) |
| HU (1) | HU223565B1 (da) |
| MX (1) | MX199501B (da) |
| NZ (1) | NZ308824A (da) |
| PT (1) | PT828703E (da) |
| SK (1) | SK282412B6 (da) |
| TW (1) | TW402581B (da) |
| UA (1) | UA56137C2 (da) |
| WO (1) | WO1996037457A1 (da) |
| YU (1) | YU48940B (da) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998004535A1 (en) * | 1996-07-26 | 1998-02-05 | Du Pont Pharmaceuticals Company | A practical synthesis of benzoxazinones useful as hiv reverse transcriptase inhibitors |
| US5874430A (en) * | 1996-10-02 | 1999-02-23 | Dupont Pharmaceuticals Company | 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same |
| AU5521498A (en) * | 1996-12-16 | 1998-07-15 | Du Pont Pharmaceuticals Company | An improved synthesis of cyclopropylacetylene |
| US5932726A (en) * | 1996-12-16 | 1999-08-03 | Dupont Pharmaceuticals Company | Asymmetric synthesis of benzoxazinones |
| JP2000507970A (ja) * | 1997-01-10 | 2000-06-27 | メルク エンド カンパニー インコーポレーテッド | キラルメディエータの効率的な合成 |
| PL197740B1 (pl) * | 1997-02-05 | 2008-04-30 | Merck & Co Inc | Postać krystaliczna I (-)-6-chloro-4-cyklopropyloetynylo-4-trifluorometylo-1,4-dihydro-2H-3,1-benzoksazyn-2-onu i sposób krystalizacji postaci I (-)-6-chloro-4-cyklopropylo-etynylo-4-trifluorometylo-1,4-dihydro-2H-3,1-benzoksazyn-2-onu |
| AU760075B2 (en) * | 1997-02-05 | 2003-05-08 | Merck Sharp & Dohme Corp. | Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
| US5965729A (en) | 1997-02-05 | 1999-10-12 | Merck & Co., Inc. | Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
| TW480253B (en) * | 1997-02-12 | 2002-03-21 | Merck & Co Inc | Efficient synthesis of a 1,4-dihydro-2H-3,1-benzoxazin-2-one |
| US5922864A (en) * | 1997-02-12 | 1999-07-13 | Merck & Co., Inc. | Efficient synthesis of a 1,4-dihydro2H-3,1-benzoxazin-2-one |
| CA2285000A1 (en) * | 1997-04-07 | 1998-10-15 | Dupont Pharmaceuticals Company | Asymmetric synthesis of benzoxazinones via new intermediates |
| AR011731A1 (es) * | 1997-05-16 | 2000-08-30 | Merck & Co Inc | Un proceso de reaccion de adicion enantioselectiva eficiente utilizando un reactivo de organozinc. |
| WO1999007657A1 (en) * | 1997-08-06 | 1999-02-18 | Merck & Co., Inc. | Efficient synthesis of cyclopropylacetylene |
| US6072094A (en) * | 1997-08-06 | 2000-06-06 | Merck & Co., Inc. | Efficient synthesis of cyclopropylacetylene |
| WO1999048848A1 (en) * | 1998-03-24 | 1999-09-30 | Great Lakes Chemical Corporation | Method to reduce the amount of phosphorus oxyhalides and dihalogenated pentenes in 1,1-dihalo-1-cyclopropylethanes |
| CO5070643A1 (es) * | 1998-05-27 | 2001-08-28 | Merck & Co Inc | Formulacion en tabletas comprimidas |
| US20010014352A1 (en) | 1998-05-27 | 2001-08-16 | Udit Batra | Compressed tablet formulation |
| EP1332757B1 (en) * | 1998-05-27 | 2012-06-13 | Merck Sharp & Dohme Corp. | Efavirenz compressed tablet formulation |
| US6673372B1 (en) | 1998-06-11 | 2004-01-06 | Bristol-Myers Squibb Pharma Company | Crystalline Efavirenz |
| HRP990182A2 (en) * | 1998-06-11 | 2000-02-29 | Du Pont Pharm Co | Crystalline efavirenz |
| US6235957B1 (en) | 1998-06-29 | 2001-05-22 | Dupont Pharmaceuticals Company | Process for the preparation of cyclopropylacetylene |
| US6288297B1 (en) | 1998-10-01 | 2001-09-11 | Dupont Pharmaceuticals Company | Process for the preparation of cyclopropylacetylene |
| WO2000018706A1 (en) | 1998-10-01 | 2000-04-06 | Du Pont Pharmaceuticals Company | Process for the preparation of cyclopropylacetylene |
| GB2355988A (en) | 1999-10-28 | 2001-05-09 | Merck & Co Inc | Synthesis of cyclopropylacetylene in a one-pot process using a diazo-keto-phos phonate |
| GB2355724A (en) | 1999-10-28 | 2001-05-02 | Merck & Co Inc | Synthesis of cyclopropylacetylene from propiolic acid (2-propynoic acid) |
| WO2004087628A1 (fr) * | 2003-04-04 | 2004-10-14 | Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences | Ligand amino-alcool et son utilisation dans la preparation d'alcools tertiaires propargyliques et d'amines tertiaires par le biais d'une reaction d'addition eniantioselective |
| CN1331601C (zh) * | 2003-05-16 | 2007-08-15 | 中国科学院上海有机化学研究所 | 手性氨基醇配体应用于端炔对含氟烷基芳基酮的不对称加成的方法 |
| US7271252B2 (en) | 2003-04-22 | 2007-09-18 | Roche Diagnostics Operations, Inc. | Reagents for detecting efavirenz |
| US7420043B2 (en) * | 2003-12-10 | 2008-09-02 | Roche Diagnostics Operations, Inc. | Reagents for detecting efavirenz |
| ZA200806473B (en) * | 2008-01-31 | 2009-04-29 | Aptuit Laurus Pvt Ltd | An efficient process to induce enantioselectivity in procarbonyl compounds |
| US9073817B2 (en) | 2008-01-31 | 2015-07-07 | Laurus Labs Private Limited | Efficient process to induce enantioselectivity in procarbonyl compounds |
| US8604189B2 (en) * | 2008-05-30 | 2013-12-10 | Emcure Pharmaceuticals Limited | Process for the preparation of Efavirenz |
| WO2010115639A1 (en) | 2009-04-09 | 2010-10-14 | Lonza Ltd | Process for the synthesis of a propargylic alcohol |
| EP2417097A2 (en) | 2009-04-09 | 2012-02-15 | Lonza Ltd. | Autocatalytic process for the synthesis of chiral propargylic alcohols |
| EP2448917A2 (de) | 2009-07-03 | 2012-05-09 | Archimica GmbH | Verfahren zur enantioselektiven addition von organometallischen kohlenstoffnukleophilen an trifluormethylketone und verwendung des verfahrens in der synthese von hiv reverse transcriptase inhibitoren |
| CN101844990B (zh) * | 2010-05-27 | 2013-03-20 | 浙江沙星医药化工有限公司 | 中间体4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的合成方法 |
| EP2447255A1 (en) | 2010-10-14 | 2012-05-02 | Lonza Ltd. | Process for the synthesis of cyclic carbamates |
| EP2447247A1 (en) | 2010-10-14 | 2012-05-02 | Lonza Ltd. | Process for the synthesis of chiral propargylic alcohols |
| EP2471783A1 (en) | 2010-12-23 | 2012-07-04 | Esteve Química, S.A. | Novel polymorphic form of efavirenz |
| CN102617370B (zh) * | 2012-03-05 | 2014-06-04 | 浙江江北药业有限公司 | (S)-5-氯-α-(环丙乙炔基)-2-(((4-甲氧基苯基)甲基)氨基)-α-(三氟甲基)苯甲醇的制备方法 |
| WO2015118515A1 (en) * | 2014-02-10 | 2015-08-13 | Discovery Intermediates Private Limited | An improved process for the preparation of a non-nucleoside reverse transcriptase inhibitor |
| CN104016936B (zh) * | 2014-06-18 | 2016-08-17 | 中国科学院上海有机化学研究所 | 手性氨基酚配体在依法韦仑不对称合成中的应用 |
| DE202015104551U1 (de) | 2015-08-27 | 2015-12-03 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Reaktoren für die Herstellung von Efavirenz sowie Zwischenprodukte |
| US9676735B2 (en) | 2015-08-27 | 2017-06-13 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Process for the preparation of efavirenz and devices suitable therefore |
| CN105801442A (zh) * | 2015-10-16 | 2016-07-27 | 浙江沙星医药化工有限公司 | 4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的制备方法 |
| JP7071036B2 (ja) | 2019-02-15 | 2022-05-18 | 福建永晶科技股▲ふん▼有限公司 | Ｆｒｉｅｄｅｌ－Ｃｒａｆｔｓ反応の新しい新方法及び当該方法に用いられる触媒 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55145625A (en) * | 1979-05-01 | 1980-11-13 | Mitsubishi Chem Ind Ltd | Preparation of alkynyl alcohol |
| JPH0436252A (ja) * | 1990-05-30 | 1992-02-06 | Nippon Alkyl Alum Kk | 光学活性アルキニルアルコールの製造方法 |
| US5663169A (en) * | 1992-08-07 | 1997-09-02 | Merck & Co., Inc. | Benzoxazinones as inhibitors of HIV reverse transcriptase |
| IL106507A (en) * | 1992-08-07 | 1997-11-20 | Merck & Co Inc | Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type |
-
1995
- 1995-05-25 US US08/450,330 patent/US5633405A/en not_active Expired - Lifetime
-
1996
- 1996-05-16 TW TW085105805A patent/TW402581B/zh not_active IP Right Cessation
- 1996-05-21 JP JP8535796A patent/JP2839717B2/ja not_active Expired - Fee Related
- 1996-05-21 KR KR1019970708374A patent/KR100399511B1/ko not_active IP Right Cessation
- 1996-05-21 HU HU9802566A patent/HU223565B1/hu active IP Right Grant
- 1996-05-21 EP EP96920322A patent/EP0828703B1/en not_active Expired - Lifetime
- 1996-05-21 MX MX9709064A patent/MX199501B/es unknown
- 1996-05-21 DE DE69610422T patent/DE69610422T2/de not_active Expired - Lifetime
- 1996-05-21 ES ES96920322T patent/ES2151666T3/es not_active Expired - Lifetime
- 1996-05-21 DK DK96920322T patent/DK0828703T3/da active
- 1996-05-21 SK SK1569-97A patent/SK282412B6/sk not_active IP Right Cessation
- 1996-05-21 AT AT96920322T patent/ATE196463T1/de active
- 1996-05-21 PT PT96920322T patent/PT828703E/pt unknown
- 1996-05-21 NZ NZ308824A patent/NZ308824A/en not_active IP Right Cessation
- 1996-05-21 AU AU58667/96A patent/AU709273B2/en not_active Expired
- 1996-05-21 EA EA199700426A patent/EA000107B1/ru not_active IP Right Cessation
- 1996-05-21 CN CN96194132A patent/CN1119319C/zh not_active Expired - Lifetime
- 1996-05-21 WO PCT/US1996/007294 patent/WO1996037457A1/en active IP Right Grant
- 1996-05-21 UA UA97126229A patent/UA56137C2/uk unknown
- 1996-05-21 BR BR9608839A patent/BR9608839A/pt not_active IP Right Cessation
- 1996-05-21 CZ CZ19973709A patent/CZ292848B6/cs not_active IP Right Cessation
- 1996-05-21 CA CA002220389A patent/CA2220389C/en not_active Expired - Lifetime
- 1996-05-22 AR AR10267196A patent/AR002997A1/es unknown
- 1996-05-23 HR HR960233A patent/HRP960233B1/xx not_active IP Right Cessation
- 1996-05-24 YU YU31496A patent/YU48940B/sh unknown
- 1996-07-15 US US08/680,940 patent/US5698741A/en not_active Expired - Lifetime
-
2000
- 2000-11-22 GR GR20000402586T patent/GR3034897T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0828703T3 (da) | Asymmetrisk syntese af (-)-6-chlor-4-cyclopropylethynyl-4-trifluormethyl-1,4-dihydro-2H-3,1-benzoxazin-2-on | |
| DK0805790T3 (da) | Forbedret syntese af cyclopropylacetylen | |
| DK0922040T3 (da) | Fremgangsmåde til fremstilling af mellemprodukter til florfenicol | |
| DK0906278T3 (da) | Enantiolselektiv syntese af azetidinoner baseret på 3-hydroxy-gamma-lacton | |
| NO982850D0 (no) | Ny syntese | |
| DK0851855T3 (da) | Derivater af melatonin deraf som lægemiddel | |
| DK0882071T3 (da) | Syntese af forgrenede polymerer | |
| DK1054860T3 (da) | Proces for syntesen af 1,3-dioler | |
| DK0908449T3 (da) | Fremstilling af carotenoider | |
| DK1032566T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
| DK0937055T3 (da) | Fremgangsmåde til fremstilling af d,I-alfa-tocopherol | |
| EE9900446A (et) | Bensoksasinoonide asümmeetriline sünteesimine uute vaheühendite kaudu | |
| HUP0001313A3 (en) | Process for the crystallization of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2h-3,1-benzoxazin-2-one | |
| DE59810008D1 (de) | Ringoszillator | |
| DK0830349T3 (da) | fremgangsmåde til fremstilling af N,N' -di-substituerede cycliske urinstoffer | |
| DK0970939T3 (da) | Fremgangsmåde til fremstilling af methanol | |
| DK0805806T3 (da) | Fremgangsmåde til fremstilling af 4,10-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxotax-11-en-13alpha- | |
| DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
| DK1023292T3 (da) | Fremgangsmåde til syntese af chlorpurinintermediater | |
| DK0915076T3 (da) | Fremgangsmåde til fremstilling af trans-(R,R)-actinol | |
| DK0721929T3 (da) | Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner | |
| DK0944610T3 (da) | Asymmetrisk syntese af benzoxazinoner | |
| DK0863874T3 (da) | Fremgangsmåde til fremstilling af dioxoazabicyclohexaner | |
| DK0927163T3 (da) | Fremstilling af 1-butyl-4-piperidinylmethylamin | |
| DK0929525T3 (da) | Heteroaryloxyethylaminer som ligander af 5-HT1A-receptor |